# Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia

> **NCT07750730** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Hospital of Traditional Chinese Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Trigeminal Neuralgia (TN)

## Interventions

- **PROCEDURE:** Trigger Point Bloodletting Therapy
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT07750730
- **Lead sponsor:** Beijing Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-31
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07750730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07750730, "Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07750730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*